Relmada Therapeutics (RLMD) Shareholder's Equity (2012 - 2026)
Relmada Therapeutics (RLMD) Shareholder's Equity (2012 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Shareholder's Equity (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
7.14 Bn |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
795.79 Mn |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
595,226.00 |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
1.00 Bn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
14.38 Mn |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
19.36 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
502.95 Mn |
| 10 |
Relmada Therapeutics |
581.07 Mn |
581.07 Mn |
- |
218.73 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
218.73 Mn |
| Dec 31, 2025 |
86.51 Mn |
| Sep 30, 2025 |
9.47 Mn |
| Jun 30, 2025 |
15.95 Mn |
| Mar 31, 2025 |
22.44 Mn |
| Dec 31, 2024 |
35.52 Mn |
| Sep 30, 2024 |
47.63 Mn |
| Jun 30, 2024 |
61.49 Mn |
| Mar 31, 2024 |
72.05 Mn |
| Dec 31, 2023 |
85.36 Mn |
| Sep 30, 2023 |
100.73 Mn |
| Jun 30, 2023 |
111.34 Mn |
| Mar 31, 2023 |
125.47 Mn |
| Dec 31, 2022 |
140.44 Mn |
| Sep 30, 2022 |
166.34 Mn |
| Jun 30, 2022 |
196.85 Mn |
| Mar 31, 2022 |
210.40 Mn |
| Dec 31, 2021 |
208.26 Mn |
| Sep 30, 2021 |
72.69 Mn |
| Jun 30, 2021 |
96.85 Mn |
